Table 1

Data collected at each assessment

≤7 day, baseline2-4 weeks3 months6 months12 months
Demographics
 Age: years
 Sex: male/female/other
 Premorbid: living, work, mobility
 Education: years
 Medical history/comorbidities
Clinically important recovery
 Fugl-Meyer Upper Limb
 Motor Assessment Scale item 6, item 7 and item 8
 Rating of Everyday Arm-use in the Community and Home
Brain biomarkers
 Motor-evoked potential (rest and active)
 MRI: T1, T2 FLAIR, diffusion tensor imaging, resting state functional MRI
 Stroke details
 Modified Rankin Scale
 National Institute of Health Stroke Scale
 Lesion location
 Lesion side, left/right
 Lesion type, ischaemic/haemorrhagic
 Acute medical/interventionalist use
Other measures
 Shoulder abduction and finger extension
 Action Research Arm Test
 Accelerometry, ratio affected/unaffected hours of use
 Canadian Occupational Performance Scale
 Global Rating of Change Scale
 Sensation, present/impaired/absent
 Independent walking, yes/no
 Montreal Cognitive Assessment
 Fatigue scale
 Stroke Impact Scale
 EQ-5D-3L
 PHQ9
  • EQ-5D-3L, EuroQol five dimension three level; FLAIR, FLuid-Attenuated Inversion Recovery; PHQ-9, Patient Health Questionnaire-9.